Communiqués Becton, Dickinson and Company Xetra

Actions

BOX

US0758871091

Equipement, fournitures et distribution médicale

Cours en clôture Xetra 07/09/2026			Varia. 5j.	Varia. 1 janv.
158,20 ^EUR	-3,62%		-2,71%	-4,93%

01/09	Medtronic relève ses prévisions annuelles après des résultats supérieurs aux attentes au premier trimestre fiscal	MT
31/08	Becton, Dickinson and Company : BofA Securities maintient sa recommandation à l'achat	ZM

Communiqués

27/08	BD Extends Leadership in Advanced Tissue Regeneration Through Continued Clinical Innovation	PR
26/08	BD to Present at Wells Fargo 21st Annual Healthcare Conference	PR
17/08	BD Appoints Gary Sorsher as Chief Quality Officer; Jeff Silvestri to Retire	PR
12/08	BD Accelerates Advanced Tissue Regeneration Strategy with Landmark PREVENT Trial	PR
06/08	Becton Dickinson: Fiscal Q3 Earnings Snapshot	AQ
06/08	BD Reports Third Quarter Fiscal 2026 Financial Results	PR
31/07	Becton Dickinson and : BD Issues Nationwide Recall for Specific Lots of BD® Intraosseous Vascular Access System Needle Sets Due to Reports of Difficulty Removing the Obturator	PU
29/07	EMS and BD expand access to GLP-1 therapies in Brazil with semaglutide launch	PR
28/07	BD Board Declares Dividend	PR
22/07	Mike Garrison to Retire from BD	PR
09/07	BD to Announce Financial Results for its Third Quarter of Fiscal 2026	PR
01/07	Becton Dickinson and : BD Appoints Matthew Sassone as Worldwide President of Pharmacy Automation	PU
23/06	BD Awarded Vizient Innovative Technology Contract for CentroVena One™ Insertion System	PR
06/06	Becton Dickinson and : BD Issues Nationwide Recall for Specific Lots of ChloraPrep™ Clear Single Sterile 1 mL and FREPP™ Clear 1.5 mL Applicators Due to Microbial Contamination	PU
21/05	BD Delivers Kidney Stone Care for Urology Teams with the Elyra™ Thulium Fiber Laser System	PR
18/05	Peter Menziuso Named EVP and President, BD Interventional	PR
07/05	Becton Dickinson: Fiscal Q2 Earnings Snapshot	AQ
07/05	Becton Dickinson and : Earnings Release Q2 FY26	PU
07/05	Becton Dickinson and : Presentation Q2 FY26	PU
07/05	BD Appoints Vitor Roque Chief Financial Officer	PR
07/05	BD Reports Second Quarter Fiscal 2026 Financial Results	PR
05/05	BD and Wellstar Advance Patient Care and Safety with Medication Management Powered by AI	PR
30/04	BD Achieves Excellence in Employee Well‑Being, Earning Top Industry Recognition	PR
29/04	BD Reimagines Central Line Insertion, Advancing Leadership in Patient Safety Through Breakthrough Vascular Access Technology	PR
28/04	BD Board Declares Dividend	PR